423
Views
4
CrossRef citations to date
0
Altmetric
Comment

Stigmata that are desired: contradictions in addiction

ORCID Icon
Pages 83-92 | Received 06 Feb 2023, Accepted 17 Jul 2023, Published online: 23 Jul 2023

References

  • American Psychiatric Association DSM-5 Task Force. 2013. Diagnostic and statistical manual of mental disorders: DSM-5. 5th ed. Washington, DC: American Psychiatric Association.
  • Atayde AMP, Hauc S, Bessette LG, Danckers H, Saitz R. 2021. Changing the narrative: a call to end stigmatizing terminology related to substance use disorders [Editorial]. Addict Res Theory. 29(5):359–362. doi:10.1080/16066359.2021.1875215.
  • Bergen SE, Gardner CO, Aggen SH, Kendler KS. 2008. Socioeconomic status and social support following illicit drug use: causal pathways or common liability? Twin Res Hum Genet. 11(3):266–274. doi:10.1375/twin.11.3.266.
  • Bierut LJ, Madden PA, Breslau N, Johnson EO, Hatsukami D, Pomerleau OF, Swan GE, Rutter J, Bertelsen S, Fox L, et al. 2007. Novel genes identified in a high-density genome wide association study for nicotine dependence. Hum Mol Genet. 16(1):24–35. doi:10.1093/hmg/ddl441.
  • Blocker JS. Jr. 2006. Did prohibition really work? Alcohol prohibition as a public health innovation. Am J Public Health. 96(2):233–243. doi:10.2105/AJPH.2005.065409.
  • Blum K, Oscar-Berman M, Demetrovics Z, Barh D, Gold MS. 2014. Genetic Addiction Risk Score (GARS): molecular neurogenetic evidence for predisposition to Reward Deficiency Syndrome (RDS). Mol Neurobiol. 50(3):765–796. doi:10.1007/s12035-014-8726-5.
  • Bos AER, Pryor JB, Reeder GD, Stutterheim SE. 2013. Stigma: advances in theory and research. Basic Appl Soc Psychol. 35(1):1–9. doi:10.1080/01973533.2012.746147.
  • Brewis A, Wutich A. 2019. Lazy, Crazy, and Disgusting: stigma and the Undoing of Global Health. Baltimore: Johns Hopkins University Press.
  • Buckingham SA, Frings D, Albery IP. 2013. Group membership and social identity in addiction recovery. Psychol Addict Behav. 27(4):1132–1140. doi:10.1037/a0032480.
  • Carmack SA, Vendruscolo JCM, Adrienne McGinn M, Miranda-Barrientos J, Repunte-Canonigo V, Bosse GD, Mercatelli D, Giorgi FM, Fu Y, Hinrich AJ, et al. 2022. Corticosteroid sensitization drives opioid addiction. Mol Psychiatry. 27(5):2492–2501. doi:10.1038/s41380-022-01501-1.
  • Caspi A, Moffitt TE. 2018. All for one and one for all: mental disorders in one dimension. Am J Psychiatry. 175(9):831–844. doi:10.1176/appi.ajp.2018.17121383.
  • CDC. 2022. U.S. Overdose deaths in 2021 increased half as much as in 2020 – but are still up 15%. National Center for Health Statistics. https://www.cdc.gov/nchs/pressroom/nchs_press_releases/2022/202205.htm
  • Chen J, Courtwright A. 2016. Stigmatization. Encyclopedia of global bioethics, Springer International Publishing. p. 2706–2712. doi:10.1007/978-3-319-09483-0_404.
  • Christie MJ. 2008. Cellular neuroadaptations to chronic opioids: tolerance, withdrawal and addiction. Br J Pharmacol. 154(2):384–396. doi:10.1038/bjp.2008.100.
  • CMC. 2022. Medicare Coverage Determination Process. Centers for Medicare & Medicaid Services. https://www.cms.gov/medicare/coverage/determinationprocess
  • Dearing RL, Stuewig J, Tangney JP. 2005. On the importance of distinguishing shame from guilt: relations to problematic alcohol and drug use. Addict Behav. 30(7):1392–1404. doi:10.1016/j.addbeh.2005.02.002.
  • Ding L, Landon BE, Wilson IB, Wong MD, Shapiro MF, Cleary PD. 2005. Predictors and consequences of negative physician attitudes toward HIV-infected injection drug users. Arch Intern Med. 165(6):618–623. doi:10.1001/archinte.165.6.618.
  • Dowell D, Haegerich TM, Chou R. 2016. CDC guideline for prescribing opioids for chronic pain – United States, 2016. JAMA. 315(15):1624–1645. doi:10.1001/jama.2016.1464.
  • Dowell D, Ragan KR, Jones CM, Baldwin GT, Chou R. 2022. Prescribing opioids for pain – The new CDC clinical practice guideline. N Engl J Med. 387(22):2011–2013. doi:10.1056/NEJMp2211040.
  • Eddie D, Bergman BG, Hoffman LA, Kelly JF. 2022. Abstinence versus moderation recovery pathways following resolution of a substance use problem: prevalence, predictors, and relationship to psychosocial well‐being in a U.S. national sample. Alcohol Clin Exp Res. 46(2):312–325. doi:10.1111/acer.14765.
  • Erickson CK, Wilcox RE. 2006. Please, not "addiction" in DSM-V. Am J Psychiatry. 163(11):2015–2016. author reply 2016-2017. doi:10.1176/ajp.2006.163.11.2015a.
  • Falconer DS. 1965. The inheritance of liability to certain diseases, estimated from the incidence among relatives. Ann Human Genet. 29(1):51–76. doi:10.1111/j.1469-1809.1965.tb00500.x.
  • Hamilton AD, Jang JB, Patrick ME, Schulenberg JE, Keyes KM. 2019. Age, period and cohort effects in frequent cannabis use among US students: 1991-2018. Addiction. 114(10):1763–1772. doi:10.1111/add.14665.
  • Heim D, Monk RL, et al. 2022. Chapter 14, Recovery is possible: overcoming ‘addiction’ and its rescue hypothesis. In: Heather N, Field M, Moss AC editors. Evaluating the brain disease model of addiction. New York, NY: Routledge; p. 144–153.
  • Heyman GM. 2013. Quitting drugs: quantitative and qualitative features. Annu Rev Clin Psychol. 9(1):29–59. doi:10.1146/annurev-clinpsy-032511-143041.
  • Holton R, Berridge K. 2013. Addiction between compulsion and choice. In: Levy N, editor. Addiction and self-control: perspectives from philosophy, psychology, and neuroscience. New York (NY): Oxford University Press; p. 239–268.
  • Hoy N, Lynch S, Waszczuk M, Reppermund S, Mewton L. 2022. Investigating the molecular genetic, genomic, brain structural, and brain functional correlates of latent transdiagnostic dimensions of psychopathology across the lifespan: protocol for a systematic review and meta-analysis of cross-sectional and longitudinal studies in the general population. Front Psychiatry. 13:1036794. doi:10.3389/fpsyt.2022.1036794.
  • Insel T, Cuthbert B, Garvey M, Heinssen R, Pine DS, Quinn K, Sanislow C, Wang P. 2010. Research Domain Criteria (RDoC): toward a new classification framework for research on mental disorders. Am J Psychiatry. 167(7):748–751. doi:10.1176/appi.ajp.2010.09091379.
  • Ivanov SA. 2006. Holy Fools in Byzantium and Beyond (Oxford Studies in Byzantium). 1st edn. New York: Oxford University Press.
  • Johnston LD, Miech RA, O’Malley PM, Bachman JG, Schulenberg JE, Patrick ME. 2022. Monitoring the Future national survey results on drug use 1975-2021: overview, key findings on adolescent drug use. Drugs and American Youth. A Report from the Youth in Transition Project. xiii:273. p.
  • Jones JM. 2022. Marijuana views linked to ideology, religiosity, age. https://news.gallup.com/poll/405086/marijuana-views-linked-ideology-religiosity-age.aspx
  • Kechichian E, Khoury E, Richa S, Tomb R. 2018. Religious stigmata: a dermato-psychiatric approach and differential diagnosis. Int J Dermatol. 57(8):885–893. doi:10.1111/ijd.13971.
  • Kendler KS, Jacobson KC, Prescott CA, Neale MC. 2003. Specificity of genetic and environmental risk factors for use and abuse/dependence of cannabis, cocaine, hallucinogens, sedatives, stimulants, and opiates in male twins. Am J Psychiatry. 160(4):687–695. doi:10.1176/appi.ajp.160.4.687.
  • Kendler KS, Myers J, Prescott CA. 2007. Specificity of genetic and environmental risk factors for symptoms of cannabis, cocaine, alcohol, caffeine, and nicotine dependence. Arch Gen Psychiatry. 64(11):1313–1320. eng. doi:10.1001/archpsyc.64.11.1313.
  • Kent GH, Rosanoff AJ. 1910. A study of association in insanity. AJP. 67(2):317–390. doi:10.1176/ajp.67.2.317.
  • Kirisci L, Vanyukov MM. 2022. Substance use: Disorders and continuous traits. In: Vanyukov MM, editor. Genetics of Substance Use: Research and Clinical Aspects. Chapter 1. Cham, Switzerland: Springer International Publishing; p. 3–54.
  • Krueger RF, Hicks BM, Patrick CJ, Carlson SR, Iacono WG, McGue M. 2002. Etiologic connections among substance dependence, antisocial behavior, and personality: modeling the externalizing spectrum. J Abnorm Psychol. 111(3):411–424. doi:10.1037/0021-843X.111.3.411.
  • Kurzban R, Leary MR. 2001. Evolutionary origins of stigmatization: the functions of social exclusion. Psychol Bull. 127(2):187–208. doi:10.1037/0033-2909.127.2.187.
  • Lahtinen H, Moustgaard H, Ripatti S, Martikainen P. 2023. Association between genetic risk of alcohol consumption and alcohol-related morbidity and mortality under different alcohol policy conditions: evidence from the Finnish alcohol price reduction of 2004. Addiction. 118(4):678–685. doi:10.1111/add.16118.
  • Leshner AI. 1997. Addiction is a brain disease, and it matters. Science. 278(5335):45–47. doi:10.1126/science.278.5335.45.
  • Liddle H. 2010. Treating adolescent substance abuse using multidimensional family therapy. In: Weisz J, Kazdin A, editors. Evidence-based psychotherapies for children and adolescents. 2nd ed. New York, NY: Guilford; p. 416–432.
  • Lloyd C. 2013. The stigmatization of problem drug users: a narrative literature review. Drugs Educ Prevent Policy. 20(2):85–95.
  • Lopez-Quintero C, Cobos JPDL, Hasin DS, Okuda M, Wang S, Grant BF, Blanco C. 2011. Probability and predictors of transition from first use to dependence on nicotine, alcohol, cannabis, and cocaine: results of the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC). Drug Alcohol Depend. 115(1-2):120–130. doi:10.1016/j.drugalcdep.2010.11.004.
  • Lopez-Quintero C, Hasin DS, De Los Cobos JP, Pines A, Wang S, Grant BF, Blanco C. 2011. Probability and predictors of remission from life-time nicotine, alcohol, cannabis or cocaine dependence: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Addiction. 106(3):657–669. doi:10.1111/j.1360-0443.2010.03194.x.
  • Maher BS, Vladimirov VI, Latendresse SJ, Thiselton DL, McNamee R, Kang M, Bigdeli TB, Chen X, Riley BP, Hettema JM, et al. 2011. The AVPR1A gene and substance use disorders: association, replication, and functional evidence. Biol Psychiatry. 70(6):519–527. doi:10.1016/j.biopsych.2011.02.023.
  • Matthews S, Dwyer R, Snoek A. 2017. Stigma and self-stigma in addiction. J Bioeth Inq. 14(2):275–286. doi:10.1007/s11673-017-9784-y.
  • McLellan AT, Koob GF, Volkow ND. 2022. Preaddiction – A missing concept for treating substance use disorders. JAMA Psychiatry. 79(8):749–751. doi:10.1001/jamapsychiatry.2022.1652.
  • Morse SJ. 2000. Hooked on hype: addiction and responsibility. Law Philos. 19(1):3–49. doi:10.2307/3505173.
  • NIDA. 2015. Dr. Nora Volkow on Addiction: a Disease of Free Will. National Institute on Drug Abuse Director, Dr. Nora Volkow, delivers the William C. Menninger Memorial Convocation Lecture during the 168th Annual Meeting of the American Psychiatric Association in Toronto, Canada. NIDA; [accessed]. https://www.drugabuse.gov/videos/dr-nora-volkow-addiction-disease-free-will.
  • O’Brien CP, Volkow N, Li T-K. 2006. What’s in a word? Addiction versus dependence in DSM-V. AJP. 163(5):764–765. doi:10.1176/ajp.2006.163.5.764.
  • Oregon ESSENCE. Oregon. 2022. Opioid overdose public health surveillance update Sept 16th 2022. Health Authority, Public Health Division. https://www.oregon.gov/oha/PH/PREVENTIONWELLNESS/SUBSTANCEUSE/OPIOIDS/Documents/monthly_opioid_overdose_related_data_report.pdf
  • Palamar JJ. 2013. An examination of beliefs and opinions about drug use in relation to personal stigmatization towards drug users. J Psychoactive Drugs. 45(5):367–373. doi:10.1080/02791072.2013.843044.
  • Palmer RH, Brick L, Nugent NR, Bidwell LC, McGeary JE, Knopik VS, Keller MC. 2015. Examining the role of common genetic variants on alcohol, tobacco, cannabis and illicit drug dependence: genetics of vulnerability to drug dependence. Addiction. 110(3):530–537. doi:10.1111/add.12815.
  • Patrick ME, Schulenberg JE, Miech RA, Johnston LD, O’Malley PM, Bachman JG. 2022. Monitoring the Future Panel Study annual report: national data on substance use among adults ages 19 to 60, 1976-2021. Ann Arbor: institute for Social Research, The University of Michigan.
  • Pulerwitz J. 2019. How stigma subverts public health: a hard-hitting study exposes the devastating effects of shame and discrimination. Nature. 575(7783):438–439. doi:10.1038/d41586-019-03531-2.
  • Rao H, Mahadevappa H, Pillay P, Sessay M, Abraham A, Luty J. 2009. A study of stigmatized attitudes towards people with mental health problems among health professionals. J Psychiatr Ment Health Nurs. 16(3):279–284. doi:10.1111/j.1365-2850.2008.01369.x.
  • Robins LN. 1993. Vietnam veterans’ rapid recovery from heroin addiction: a fluke or normal expectation? The Sixth Thomas James Okey Memorial Lecture. Addiction. 88(8):1041–1054. doi:10.1111/j.1360-0443.1993.tb02123.x.
  • Robins LN, Helzer JE, Hesselbrock M, Wish E. 2010. Vietnam veterans three years after Vietnam: how our study changed our view of heroin. Am J Addict. 19(3):203–211. doi:10.1111/j.1521-0391.2010.00046.x.
  • Saccone SF, Hinrichs AL, Saccone NL, Chase GA, Konvicka K, Madden PAF, Breslau N, Johnson EO, Hatsukami D, Pomerleau O, et al. 2007. Cholinergic nicotinic receptor genes implicated in a nicotine dependence association study targeting 348 candidate genes with 3713 SNPs. Hum Mol Genet. 16(1):36–49. doi:10.1093/hmg/ddl438.
  • SAMHSA. 2021. Key substance use and mental health indicators in the United States: results from the 2020 National Survey on Drug Use and Health. Substance Abuse and Mental Health Services Administration.
  • Satel S. 2007. Chapter 19, In praise of stigma. In: Henningfield JE, Santora PB, Bickel WK, editors. Addiction Treatment: science and Policy for the Twenty-First Century. Baltimore, MD: The Johns Hopkins University Press; p. 147–151.
  • Scarr S, McCartney K. 1983. How people make their own environments: a theory of genotype greater than environment effects. Child Dev. 54(2):424–435. doi:10.2307/1129703.
  • Schaumberg RL, Skowronek SE. 2022. Shame Broadcasts Social Norms: the positive social effects of shame on norm acquisition and normative behavior. Psychol Sci. 33(8):1257–1277. doi:10.1177/09567976221075303.
  • Schwantes-An TH, Zhang J, Chen LS, Hartz SM, Culverhouse RC, Chen X, Coon H, Frank J, Kamens HM, Konte B, et al. 2016. Association of the OPRM1 variant rs1799971 (A118G) with non-specific liability to substance dependence in a collaborative de novo meta-analysis of European-ancestry cohorts. Behav Genet. 46(2):151–169. doi:10.1007/s10519-015-9737-3.
  • Sliedrecht W, Roozen H, de Waart R, Dom G, Witkiewitz K. 2022. Variety in alcohol use disorder relapse definitions: should the term "relapse" be abandoned? J Stud Alcohol Drugs. 83(2):248–259. eng. doi:10.15288/jsad.2022.83.248.
  • Smith W. 1859. Dictionary of Greek and Roman Antiquities. 2nd ed. Boston: Little, Brown, and Company.
  • Smyth BP, Cannon M. 2021. Cannabis legalization and adolescent cannabis use: explanation of paradoxical findings. J Adolesc Health. 69(1):14–15. doi:10.1016/j.jadohealth.2021.02.025.
  • Spoor JR, Williams KD. 2007. The evolution of an ostracism detection system. In: Forgas JP, Haselton MG, von Hippel W, editors. Evolution and the Social Mind: evolutionary Psychology and Social Cognition. New York: Psychology Press; p. 279–292.
  • Szutorisz H, Hurd YL. 2022. Overcoming addiction stigma: epigenetic contributions to substance use disorders and opportunities for intervention. Neuron. 110(10):1611–1614. doi:10.1016/j.neuron.2022.03.018.
  • Tarter RE, Vanyukov M. 1994. Alcoholism: a developmental disorder. J Consult Clin Psychol. 62(6):1096–1107. doi:10.1037//0022-006x.62.6.1096.
  • Tsuang MT, Lyons MJ, Meyer JM, Doyle T, Eisen SA, Goldberg J, True W, Lin N, Toomey R, Eaves L. 1998. Co-occurrence of abuse of different drugs in men: the role of drug-specific and shared vulnerabilities. Arch Gen Psychiatry. 55(11):967–972. doi:10.1001/archpsyc.55.11.967.
  • van Boekel LC, Brouwers EP, van Weeghel J, Garretsen HF. 2013. Stigma among health professionals towards patients with substance use disorders and its consequences for healthcare delivery: systematic review. Drug Alcohol Depend. 131(1-2):23–35. doi:10.1016/j.drugalcdep.2013.02.018.
  • Vanyukov MM. 2012. Substance-specific symptoms and general liability to addiction. Am J Psychiatry. 169(10):1016–1018. doi:10.1176/appi.ajp.2012.12070923.
  • Vanyukov MM. 2021. An eternal epidemic: 1. Why substance use problems persist [Preprint]. PsyArXiv. https://psyarxiv.com/tkm5u/.
  • Vanyukov MM, Tarter RE. 2019. Chapter 4, Genetics and epigenetics of substance use. In: Sloboda Z, Petras H, Robertson EB editors. Prevention of Substance Use. New York: springer Publishers; p. 57–73.
  • Vanyukov MM, Tarter RE, Conway KP, Kirillova GP, Chandler RK, Daley DC. 2016. Risk and resistance perspectives in translation-oriented etiology research. Transl Behav Med. 6(1):44–54. doi:10.1007/s13142-015-0355-7.
  • Vanyukov MM, Tarter RE, Kirisci L, Kirillova GP, Maher BS, Clark DB. 2003. Liability to substance use disorders: 1. Common mechanisms and manifestations. Neurosci Biobehav Rev. 27(6):507–515. doi:10.1016/j.neubiorev.2003.08.002.
  • Volkow N. 2015. Addiction is a disease of free will. HuffPost Contributor. https://www.huffpost.com/entry/addiction-is-a-disease-of_b_7561200
  • Volkow ND. 2020a. Addressing the stigma that surrounds addiction. Scientific American. https://blogs.scientificamerican.com/observations/addressing-the-stigma-that-surrounds-addiction/
  • Volkow ND. 2020b. Stigma and the toll of addiction. N Engl J Med. 382(14):1289–1290. doi:10.1056/NEJMp1917360.
  • Volkow ND, Li T-K. 2004. Drug addiction: the neurobiology of behaviour gone awry. Nat Rev Neurosci. 5(12):963–970. doi:10.1038/nrn1539.
  • Volkow ND, McLellan AT. 2016. Opioid abuse in chronic pain – misconceptions and mitigation strategies. N Engl J Med. 374(13):1253–1263. doi:10.1056/NEJMra1507771.
  • Weinstein RM. 1980. Vocabularies of motive for illicit drug use: An application of the Accounts Framework. The Sociological Quarterly. 21(4):577–593. doi:10.1111/j.1533-8525.1980.tb00637.x.
  • Winick C. 1962. Maturing out of narcotic addiction. United Nations Office on Drugs and Crime. https://www.unodc.org/unodc/en/data-and-analysis/bulletin/bulletin_1962-01-01_1_page002.html

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.